064550 — BioneerCorp Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩774bn
- KR₩787bn
- KR₩263bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 25,236 | 59,819 | 79,676 | 80,035 | 43,285 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 4,657 | 13,535 | 22,061 | 13,957 | 12,495 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 43,023 | 95,059 | 136,388 | 134,086 | 147,680 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 31,842 | 83,012 | 113,538 | 151,534 | 151,918 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 82,100 | 191,166 | 262,418 | 298,737 | 315,487 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 36,029 | 35,143 | 50,785 | 36,237 | 53,739 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 51,491 | 45,560 | 59,370 | 62,735 | 91,611 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 30,609 | 145,606 | 203,049 | 236,002 | 223,876 |
Total Liabilities & Shareholders' Equity | 82,100 | 191,166 | 262,418 | 298,737 | 315,487 |
Total Common Shares Outstanding |